Fewer Medicare patients dying in hospital setting

This article originally appeared here.
Fewer Medicare Patients Dying in Hospital Setting
Fewer Medicare Patients Dying in Hospital Setting

(HealthDay News) -- Fewer Medicare beneficiaries are dying in the setting of acute care hospitals, but health care transitions and intensive care unit (ICU) utilization are increasing in the last month of life, according to a study published in the Feb. 6 issue of the Journal of the American Medical Association.

Joan M. Teno, M.D., from Brown University in Providence, R.I., and colleagues retrospectively analyzed data from a random 20-percent sample of fee-for-service Medicare beneficiaries, aged 66 years and older, who died in 2000 (270,202 decedents), 2005 (291,819), or 2009 (286,282). Billing data was used to identify medical diagnosis of cancer, chronic obstructive pulmonary disease, or dementia in the last 180 days of life.

The researchers observed a significant decrease in deaths occurring in the setting of acute care hospitals, accompanied by increases in ICU use in the last 30 days, hospice use at the time of death, and health care transitions in the last days of life. Of those in hospice at the time of death, 28.4 percent used hospice for three days or less in 2009, and of these late hospice referrals, 40.3 percent had just had a hospitalization with an ICU stay.

"Among Medicare beneficiaries who died in 2009 and 2005 compared with 2000, a lower proportion died in an acute care hospital, although both ICU use and the rate of health care transitions increased in the last month of life," the authors write.

Several authors disclosed receiving financial compensation for speaking and consulting on end-of-life issues.

Full Text
Editorial (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs